Theratechnologies año OPV
¿Qué es el año OPV de Theratechnologies?
El año OPV de Theratechnologies Inc. es 2009
¿Cuál es la definición de año OPV?
La oferta pública inicial es un tipo de oferta pública en la cual las acciones de una compañía generalmente se venden a inversionistas institucionales que, a su vez, venden al público en general, en una bolsa de valores, por primera vez.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
año OPV de compañías en Sector Health Care en NASDAQ en comparadas con Theratechnologies
¿Qué hace Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Empresas con año opv similar a Theratechnologies
- Xiana Mining tiene año OPV de 2008
- Bassari Resources tiene año OPV de 2008
- ITV Plc tiene año OPV de 2008
- Calfrac Well Services tiene año OPV de 2008
- Consolidated Tin Mines tiene año OPV de 2008
- Ocean Agro (India) tiene año OPV de 2008
- Theratechnologies tiene año OPV de 2009
- Wow Unlimited Media tiene año OPV de 2010
- Generac Inc tiene año OPV de 2010
- Standard AVB tiene año OPV de 2010
- AB Science S.A tiene año OPV de 2010
- Hudson Pacific Properties Inc tiene año OPV de 2010
- Cencora tiene año OPV de 2010